Jon Sudbø

1.6k total citations
20 papers, 606 citations indexed

About

Jon Sudbø is a scholar working on Periodontics, Molecular Biology and Cancer Research. According to data from OpenAlex, Jon Sudbø has authored 20 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Periodontics, 5 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Jon Sudbø's work include Oral Health Pathology and Treatment (6 papers), Head and Neck Cancer Studies (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Jon Sudbø is often cited by papers focused on Oral Health Pathology and Treatment (6 papers), Head and Neck Cancer Studies (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Jon Sudbø collaborates with scholars based in Norway, United Kingdom and United States. Jon Sudbø's co-authors include Scott M. Lippman, Waun Ki Hong, Albrecht Reith, Morten Boysen, Paul M. Speight, C Scully, Vera M. Abeler, Jahn M. Nesland, Gunnar B. Kristensen and Magne Bryne and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and European Journal of Cancer.

In The Last Decade

Jon Sudbø

17 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Sudbø Norway 11 226 170 153 153 98 20 606
R.C.K. Jordan Canada 8 282 1.2× 49 0.3× 33 0.2× 100 0.7× 58 0.6× 9 446
Z. Nora Tu United States 9 183 0.8× 16 0.1× 79 0.5× 209 1.4× 69 0.7× 14 398
Dapeng Lei China 17 347 1.5× 9 0.1× 130 0.8× 226 1.5× 176 1.8× 62 734
W Famulski Poland 15 248 1.1× 20 0.1× 15 0.1× 251 1.6× 57 0.6× 59 604
Timon P.H. Buys Canada 12 369 1.6× 19 0.1× 21 0.1× 154 1.0× 56 0.6× 18 635
Yasir Suliman United States 7 190 0.8× 11 0.1× 33 0.2× 177 1.2× 79 0.8× 8 424
Kevin Furlong United States 6 103 0.5× 14 0.1× 39 0.3× 207 1.4× 75 0.8× 14 381
Aditi Chandra India 15 251 1.1× 10 0.1× 31 0.2× 133 0.9× 57 0.6× 36 666
Atsuro Sugita Japan 12 173 0.8× 15 0.1× 12 0.1× 178 1.2× 72 0.7× 27 456
Tarig Osman Norway 11 165 0.7× 30 0.2× 18 0.1× 60 0.4× 25 0.3× 22 329

Countries citing papers authored by Jon Sudbø

Since Specialization
Citations

This map shows the geographic impact of Jon Sudbø's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Sudbø with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Sudbø more than expected).

Fields of papers citing papers by Jon Sudbø

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Sudbø. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Sudbø. The network helps show where Jon Sudbø may publish in the future.

Co-authorship network of co-authors of Jon Sudbø

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Sudbø. A scholar is included among the top collaborators of Jon Sudbø based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Sudbø. Jon Sudbø is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kildal, Wanja, Bjørn Risberg, Vera M. Abeler, et al.. (2005). β-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: A study in 253 patients. European Journal of Cancer. 41(8). 1127–1134. 54 indexed citations
2.
Lilleby, Wolfgang, Jon Sudbø, & Sophie D. Fosså. (2005). [Biology and treatment options during the development of prostate cancer].. PubMed. 125(5). 571–4. 1 indexed citations
3.
Lippman, Scott M., Jon Sudbø, & Waun Ki Hong. (2005). Oral Cancer Prevention and the Evolution of Molecular-Targeted Drug Development. Journal of Clinical Oncology. 23(2). 346–356. 143 indexed citations
4.
Sudbø, Jon, S. M. Lippman, Jon Mork, et al.. (2005). Non-steroidal anti-inflammatory drugs and the risk of oral cancer in current and former smokers - [REMOVED]. Journal of Clinical Oncology. 23(16_suppl). 1007–1007.
5.
Kildal, Wanja, J. Kærn, Sigrid Marie Kraggerud, et al.. (2004). Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors—relation to clinicopathologic variables. Cancer Genetics and Cytogenetics. 155(1). 25–32. 10 indexed citations
6.
Sudbø, Jon, et al.. (2003). COX‐2 expression in striated muscle under physiological conditions. Oral Diseases. 9(6). 313–316. 8 indexed citations
7.
Sudbø, Jon & Albrecht Reith. (2003). Which putatively pre‐malignant oral lesions become oral cancers?. Journal of Oral Pathology and Medicine. 32(2). 63–70. 34 indexed citations
8.
Scully, C, Jon Sudbø, & Paul M. Speight. (2003). Progress in determining the malignant potential of oral lesions. Journal of Oral Pathology and Medicine. 32(5). 251–256. 66 indexed citations
9.
Sudbø, Jon. (2003). Forskningsprosjekt: Pasienter med høy risiko for munnhulekreft ønskes henvist. ˜Den œNorske tannlegeforenings tidende. 113(7).
10.
Sudbø, Jon. (2003). Kjemoprevensjon av munnhulekreft. ˜Den œNorske tannlegeforenings tidende. 113(7).
11.
Sudbø, Jon, Wanja Kildal, Anne Christine Johannessen, et al.. (2002). Gross Genomic Aberrations in Precancers: Clinical Implications of a Long-Term Follow-Up Study in Oral Erythroplakias. Journal of Clinical Oncology. 20(2). 456–462. 36 indexed citations
12.
Sudbø, Jon. (2002). Gross Genomic Aberrations in Precancers: Clinical Implications of a Long-Term Follow-Up Study in Oral Erythroplakias. Journal of Clinical Oncology. 20(2). 456–462. 23 indexed citations
13.
Sudbø, Jon, Ágnes Bánkfalvi, Magne Bryne, et al.. (2000). Prognostic Value of Graph Theory-Based Tissue Architecture Analysis in Carcinomas of the Tongue. Laboratory Investigation. 80(12). 1881–1889. 18 indexed citations
14.
Sudbø, Jon, et al.. (2000). New Algorithms Based on the Voronoi Diagram Applied in a Pilot Study on Normal Mucosa and Carcinomas. Analytical Cellular Pathology. 21(2). 71–86. 40 indexed citations
15.
Sudbø, Jon, et al.. (2000). Caveats: Numerical Requirements in Graph Theory Based Quantitation of Tissue Architecture. Analytical Cellular Pathology. 21(2). 59–69. 8 indexed citations
16.
Danielsen, Håvard E., Wanja Kildal, & Jon Sudbø. (2000). [Digital image analysis in pathology--exemplified in prostatic cancer].. PubMed. 120(4). 479–88. 4 indexed citations
17.
Bryne, Magne, Morten Boysen, G. Cecilie Alfsen, et al.. (1999). The invasive front of carcinomas. The most important area for tumour prognosis?. PubMed. 18(6B). 4757–64. 112 indexed citations
18.
Sudbø, Jon, et al.. (1997). Diagnostic implications of p53 protein reactivity in nasal mucosa of nickel workers.. PubMed. 19(4). 345–50. 8 indexed citations
19.
Xie, Xin, O. P. F. Clausen, Jon Sudbø, & Morten Boysen. (1997). Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity. Cancer. 79(11). 2200–2208. 1 indexed citations
20.
Xie, Xin, O. P. F. Clausen, Jon Sudbø, & Morten Boysen. (1997). Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity. Cancer. 79(11). 2200–2208. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026